OLMAOlema Pharmaceuticals, Inc.DowntrendEarnings in 13 days

TodayDowntrendjumpy stock

Nasdaq GSBiotechnologyMarket cap $579.23MReports Nov 9, 2026

Olema Pharmaceuticals, Inc.

Oncology
Sector
Healthcare
Industry
Biotechnology
Market cap
$579.23M
Employees
150
Exchange
Nasdaq GS
Country
United States
Website
olema.com
6.62+3.28% todayClose of Oct 26, 2026 · end-of-day snapshot

Not sure what's inside? Read a full TSLA analysis, currently free

Figures as of Oct 26, 2026Unlock all 8$9.90one-time

Technical readingsFree

Trend state Downtrend, stage 4 of 4, 3 of 4 damage flags raised (as of Oct 26, 2026)

Automated read

Price is trading below its key moving averages: the mid-term picture reads as a downtrend. RSI is currently 30.

Readings, end-of-day Oct 26, 2026
RSI (14)Lower-neutral30.13, caution reading
MACD / signalAbove signal line-0.72 / -0.74, favorable reading
SMA 50Price below9.13, caution reading
SMA 200Price below14.45, caution reading
EMA 20Price below7.51, caution reading
ADX (14)Trending40.80
Show all 12 readings
+DI / −DI−DI leading11.82 / 32.68, caution reading
ATR (14)7.1% of price — elevated daily swings0.47, flagged reading
Stochastic %KOversold zone19.30, flagged reading
Bollinger bands (20)Inside bands6.08 – 8.87
ROC (10)Negative over 10 sessions-10.05, caution reading
Trend / momentum impulseTrend and momentum disagreeMixed
Full analysis

What unlocking OLMA reveals

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when OLMA's analysis runs, rather than checked against its stored data now.

Every section above, argued on OLMA's own numbers, on one page.

See what OLMA costsNot sure what's inside? Read a full TSLA analysis, currently free

Unlock the full OLMA analysis

AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.

  • Unlocked in about 60 seconds
  • No account needed
  • Secure checkout via Stripe

Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.

Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get OLMA + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
Earnings

When does Olema Pharmaceuticals, Inc. report earnings?

Olema Pharmaceuticals, Inc. (OLMA) is scheduled to report earnings on Nov 9, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Oct 27, 2026

See who else reports soon
Data dictionary
$9.90one-time Unlock OLMA